Category Specific RSS

IBX

Imagion Biosystems Advances MagSense® Phase 2 Trial

Imagion Biosystems (ASX: IBX) is moving its MagSense® HER2 Imaging Agent Phase 1b/2 clinical trial towards patient enrolment, with key…

1 week ago

Imagion and Siemens Healthineers to collaborate on cancer detection agent

Biotech company Imagion Biosystems (ASX: IBX) has secured a major boost in resources having secured Siemens Healthineers (FWB: SHL) as…

6 years ago